Driehaus Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Driehaus Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-373,175	Closed	-$6.45M	–	447
2021 Q2	$6.45M	Sell	373,175 -143,128	-28%	-$2.56M	0.09%	263
2021 Q1	$10.2M	Sell	516,303 -28,038	-5%	-$537K	0.15%	202
2020 Q4	$9.5M	Buy	544,341 +434,341	+395%	+$8.54M	0.15%	186
2020 Q3	$2.12M	Buy	110,000 +20,000	+22%	+$429K	0.04%	256
2020 Q2	$1.75M	Buy	+90,000	New	+$1.5M	0.04%	265

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Driehaus Capital Management's MIRM Position: Q3 2021 in Review

Driehaus Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q3 2021, closing a stake of 373,175 shares — an estimated $6.45M sold.

Driehaus Capital Management first reported a position in MIRM in Q2 2020 and held it in 5 quarters. The position peaked at $10.2M in Q1 2021. 73 funds tracked by Wall St. Rank hold MIRM as of Q3 2021.

Driehaus Capital Management reported no remaining Mirum Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Driehaus Capital Management sold 373,175 Mirum Pharmaceuticals shares in Q3 2021, an estimated $6.45M.
Driehaus Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2020 and held it in 5 quarters.
Driehaus Capital Management's Mirum Pharmaceuticals position peaked at $10.2M in Q1 2021.
73 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2021.

Based on Driehaus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.